Significantly, CIP was shown to be down-regulated in various human heart diseases at both the mRNA and protein levels, indicating CIP plays an important regulatory role in the pathogenesis of human heart diseases and could be a target for reversing the adverse effects of the remodeling process and remodeling itself, thereby preventing heart failure. The gene discussed is MLIP; the disease is heart failure.